Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $5,616 - $6,096
100 Added 2.5%
4,100 $248,000
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $21,432 - $22,808
400 Added 11.11%
4,000 $224,000
Q1 2024

May 01, 2024

SELL
$42.56 - $59.82 $8,512 - $11,964
-200 Reduced 5.26%
3,600 $203,000
Q4 2023

Feb 12, 2024

SELL
$32.18 - $46.57 $102,976 - $149,024
-3,200 Reduced 45.71%
3,800 $170,000
Q3 2023

Nov 13, 2023

SELL
$44.2 - $50.2 $2.12 Million - $2.41 Million
-48,000 Reduced 87.27%
7,000 $318,000
Q2 2023

Aug 10, 2023

BUY
$31.86 - $67.26 $1.62 Million - $3.41 Million
50,700 Added 1179.07%
55,000 $2.38 Million
Q1 2023

May 09, 2023

SELL
$45.44 - $74.26 $786,112 - $1.28 Million
-17,300 Reduced 80.09%
4,300 $282,000
Q4 2022

Feb 10, 2023

BUY
$41.39 - $81.0 $794,688 - $1.56 Million
19,200 Added 800.0%
21,600 $971,000
Q3 2022

Nov 10, 2022

BUY
$72.36 - $113.1 $57,888 - $90,480
800 Added 50.0%
2,400 $174,000
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $749,920 - $980,830
-8,600 Reduced 84.31%
1,600 $172,000
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $395,598 - $522,858
4,200 Added 70.0%
10,200 $1.13 Million
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $578,601 - $754,455
5,300 Added 757.14%
6,000 $798,000
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $50,170 - $57,845
-500 Reduced 41.67%
700 $75,000
Q1 2021

May 17, 2021

SELL
$101.51 - $125.27 $60,906 - $75,162
-600 Reduced 33.33%
1,200 $126,000
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $68,704 - $84,288
800 Added 80.0%
1,800 $187,000
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $72,740 - $92,500
1,000 New
1,000 $86,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.